Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PALOMA-3: Palbociclib plus Fulvestrant in Advanced Breast Cancer
NCT01942135Phase 3Completed
- Sponsor
- Pfizer
- Start
- Sep 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 3 trial of palbociclib in breast cancer, sponsored by Pfizer. Started Sep 2013; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01942135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01942135.